Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1993
Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers
W Sheikh, D H Pitkin, H Nadler
The Journal of Antimicrobial Chemotherapy
|
September 1, 1989
Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay
D H Pitkin, W Sheikh, H Nadler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers
D H Pitkin, W Sheikh, H L Nadler
Journal of Pharmaceutical Sciences
|
March 1, 1980
Serum protein binding alterations of selected cephalosporin antibiotics by fatty acids and their derivatives
D H Pitkin, P Actor, J A Weisbach
The Journal of Antimicrobial Chemotherapy
|
September 1, 1989
The postantibiotic effect of meropenem and imipenem on selected bacteria
H L Nadler, D H Pitkin, W Sheikh
Acta Microbiologica Hungarica
|
January 1, 1986
Comparative laboratory studies on alpha-methoxyimino furyl- and phenylacetamido cephalosporins: structure-activity relationships
J V Uri, L Phillips, D H Pitkin
Antimicrobial Agents and Chemotherapy
|
April 1, 1977
Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits
D H Pitkin, C Sachs, I Zajac, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1994
Are all carbapenems created equal?
J P Iaconis, H L Nadler, D H Pitkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials
J P Iaconis, D H Pitkin, W Sheikh, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1986
Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics
D H Pitkin, B A Mico, R D Sitrin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1993
Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers
W Sheikh, D H Pitkin, H Nadler
The Journal of Antimicrobial Chemotherapy
|
September 1, 1989
Development of a meropenem susceptibility disc: drug content, preliminary interpretive and quality control criteria and potency bioassay
D H Pitkin, W Sheikh, H Nadler
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers
D H Pitkin, W Sheikh, H L Nadler
Journal of Pharmaceutical Sciences
|
March 1, 1980
Serum protein binding alterations of selected cephalosporin antibiotics by fatty acids and their derivatives
D H Pitkin, P Actor, J A Weisbach
The Journal of Antimicrobial Chemotherapy
|
September 1, 1989
The postantibiotic effect of meropenem and imipenem on selected bacteria
H L Nadler, D H Pitkin, W Sheikh
Acta Microbiologica Hungarica
|
January 1, 1986
Comparative laboratory studies on alpha-methoxyimino furyl- and phenylacetamido cephalosporins: structure-activity relationships
J V Uri, L Phillips, D H Pitkin
Antimicrobial Agents and Chemotherapy
|
April 1, 1977
Distribution of sodium cefazolin in serum, muscle, bone marrow, and bone of normal rabbits
D H Pitkin, C Sachs, I Zajac, et al.
The Journal of Antimicrobial Chemotherapy
|
September 1, 1994
Are all carbapenems created equal?
J P Iaconis, H L Nadler, D H Pitkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 1, 1997
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials
J P Iaconis, D H Pitkin, W Sheikh, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1986
Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics
D H Pitkin, B A Mico, R D Sitrin, et al.
Page
of 2